Skip to main content
Signal8

Moore Duncan

SEC insider (Form 3/4/5 filer). CIK 0001888265. Director at GH Research PLC (GHRS) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Aug 11, 2026. Located in DUBLIN.

Companies Moore Duncan has filed insider reports for

  • GH Research PLC (GHRS): Director
  • ASP Isotopes Inc. (ASPI): Director
Moore Duncan profile photo

Moore Duncan

CIK: 0001888265

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

GH Research PLC logo
GHRS

GH Research PLC

Director
ASP Isotopes Inc. logo
ASPI

ASP Isotopes Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • GH Research PLC logo
    GHRS

    GH Research PLC

    Aug 11, 2026
    Award

    Share Options (Right to Buy)

    Direct
    2.2K shares-
  • ASP Isotopes Inc. logo
    ASPI

    ASP Isotopes Inc.

    Apr 16, 2026
    Sale
    Direct
    11.6K shares at avg. $5.21$61K
  • ASP Isotopes Inc. logo
    ASPI

    ASP Isotopes Inc.

    Dec 18, 2025
    Award
    Direct
    36.5K shares-
  • ASP Isotopes Inc. logo
    ASPI

    ASP Isotopes Inc.

    Nov 12, 2025
    Award
    Direct
    25.5K shares-
  • ASP Isotopes Inc. logo
    ASPI

    ASP Isotopes Inc.

    Aug 29, 2025
    Sale
    Direct
    75K shares at avg. $9.28$696K
  • ASP Isotopes Inc. logo
    ASPI

    ASP Isotopes Inc.

    Dec 9, 2024
    Award
    Direct
    77.6K shares-
  • ASP Isotopes Inc. logo
    ASPI

    ASP Isotopes Inc.

    Dec 9, 2024
    Award
    Direct
    95.2K shares-
  • ASP Isotopes Inc. logo
    ASPI

    ASP Isotopes Inc.

    Nov 20, 2024
    Award
    Direct
    42.5K shares-

1-8 of 8